Publications by authors named "Anja Dahten"

B lymphocytes play a fundamental role in the development of IgE-dependent allergic immune reactions. Upon appropriate activation, IgE class switch recombination is initiated in B cells, followed by terminal differentiation to IgE-secreting plasmablasts. This process is controlled by different nuclear receptors, including receptors for vitamin D, retinoids, and peroxisome proliferator-activated receptor-gamma ligands.

View Article and Find Full Text PDF

We have shown previously that specific ligands of the peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit the systemic allergic immune response. The objective of this study was to investigate the impact of PPARgamma-ligand treatment on the local allergic immune response. We established a murine model exhibiting clinical and histological features of AD-like skin lesions with high reproducibility.

View Article and Find Full Text PDF

Vitamin A (VA) and its derivatives, the retinoids, are important factors for the development of the immune system. It has been shown in adult animals that proliferation of lymphocyte populations and antibody secretion are retinoid dependent, while little is known about the effects of retinoids during postnatal development. The aim of this study was to investigate the role of VA on allergic sensitisation during lactation and after weaning using an in vivo system for postnatal allergic sensitisation in mice.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigated how specific ligands of peroxisome proliferator-activated receptors (PPAR-alpha and PPAR-gamma) affect immunoglobulin (IgE) and cytokine production in donors with and without atopic dermatitis.
  • Significant reduction in IgE synthesis was found in atopic dermatitis donors, with PPAR-gamma ligands showing the highest inhibitory effect, while production of other immunoglobulin types (IgA, IgG, IgM) was only slightly affected.
  • In vivo experiments with ovalbumin-sensitized mice aligned with the in vitro results, confirming that treatment with ciglitazone significantly inhibited interleukin-4-mediated immune responses.
View Article and Find Full Text PDF